High Signal Podcasts Evidence ledger
Method
Browse

Evidence index / named items

Books, apps, and tools people actually name.

Compare how many distinct people recommended, used, liked, owned, built, or avoided the same item—then inspect every transcript excerpt behind the count.

1named items

1evidence rows on this page

Explicitquote verified; attribution disclosed

← Back to grouped items

other / evidence rows

New York Times

1 distinct person

uses / other

“The first time I heard about Mounjaro was 18 months after I'd heard about Ozempic, and I was like, oh, it must be some kind of knockoff. It's my first time studying pharma. I was like, oh, it's probably something crappy that's trying to ride this same wave, but isn't actually the breakthrough molecule. The studies show, Mounjaro helps you lose more weight and has a very similar mechanism, plus another mechanism that together worked, but most people don't know that. Most people know, I read on the cover of the New York Times that Ozempic is a breakthrough, and I heard about it at the Oscars because a joke was made on stage.”

Ben Gilbert · Acquired · Novo Nordisk (Ozempic) · 22 Jan 2024

Source · Claim receipt

Search evidence